1 Gross O,Yazdi AS,Thomas CJ,et al.Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1[J].Immunity,2012,36(3):388-400.

2 Guarda G,Zenger M,Yazdi AS,et al.Differential expression of NLRP3 among hematopoietic cells[J].J Immunol,2011,186(4):2529-2534.

3 Sutterwala FS,Ogura Y,Szczepanik M,et al.Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1[J].Immunity,2006,24(3):317-327.

4 Lamkanfi M,Kanneganti TD.NLRP3:an immune sensor of cellular stress and infection[J].Int J Biochem Cell Biol,2010,42(6):792-795.

5 Hoffman HM,Mueller JL,Broide DH,et al.Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome[J].Nat Genet,2001,29(3):301-305.

6 Agostini L,Martinon F,Burns K,et al.NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder[J].Immunity,2004,20(3):319-325.

7 Martinon F,Burns K,Tschopp J.The inflammasome:a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta[J].Mol Cell,2002,10(2):417-426.

8 Sutterwala FS,Haasken S,Cassel SL.Mechanism of NLRP3 inflammasome activation[J].Ann N Y Acad Sci,2014,1319(1):82-95.

9 Horvath GL,Schrum JE,De Nardo CM,et al.Intracellular sensing of microbes and danger signals by the inflammasomes[J].Immunol Rev,2011,243(1):119-135.

10 Lee GS,Subramanian N,Kim AI,et al.The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP[J].Nature,2012,492(7427):123-127.

11 Martinon F.Mechanisms of uric acid crystal-mediated autoinflammation[J].Immunol Rev,2010,233(1):218-232.

12 Dai M,Yang Y,Omelchenko I,et al.Bone marrow cell recruitment mediated by inducible nitric oxide synthase/stromal cell-derived factor-1alpha signaling repairs the acoustically damaged cochlear blood-labyrinth barrier[J].Am J Pathol,2010,177(6):3089-3099.

13 Shi X.Resident macrophages in the cochlear blood-labyrinth barrier and their renewal via migration of bone-marrow-derived cells[J].Cell Tissue Res,2010,342(1):21-30.

14 Chae JJ,Cho YH,Lee GS,et al.Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice[J].Immunity,2011,34(5):755-768.

15 Chen P,He L,Pang X,et al.NLRP3 is expressed in the spiral ganglion neurons and associated with both syndromic and nonsyndromic sensorineural deafness[J].Neural Plast,2016(2016),2016:3018132-3018132.

16 Shi X,Dong Y,Li Y,et al.Inflammasome activation in mouse inner ear in response to MCMV induced hearing loss[J].J Otol,2015,10(4):143-149.

17 Zhuang W,Wang C,Shi X,et al.MCMV triggers ROS/NLRP3-associated inflammasome activation in the inner ear of mice and cultured spiral ganglion neurons,contributing to sensorineural hearing loss[J].Int J Mol Med,2018,41(6):3448-3456.

18 Rodríguez-Valiente A,álvarez-Montero ó,Górriz-Gil C,et al.Prevalence of presbycusis in an otologically normal population[J].Acta Otorrinolaringol Esp,2019,71(3):175-180.

19 Riva C,Donadieu E,Magnan J,et al.Age-related hearing loss in CD/1 mice is associated to ROS formation and HIF target proteins up-regulation in the cochlea[J].Exp Gerontol,2007,42(4):327-336.

20 Zheng Q,Ren Y,Reinach PS,et al.Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye[J].Exp Eye Res,2014,125(125):1-8.

21 Shi X,Qiu S,Zhuang W,et al.NLRP3-inflammasomes are triggered by age-related hearing loss in the inner ear of mice[J].Am J Transl Res,2017,9(12):5611-5618.

22 Aksentijevich I,Nowak M,Mallah M,et al.De novo CIAS1 mutations,cytokine activation,and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID):a new member of the expanding family of pyrin-associated autoinflammatory diseases[J].Arthritis Rheum,2002,46(12):3340-3348.

23 Goldbach-Mansky R,Dailey NJ,Canna SW,et al.Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition[J].N Engl J Med,2006,355(6):581-592.

24 Ahmadi N,Brewer CC,Zalewski C,et al.Cryopyrin-associated periodic syndromes:otolaryngologic and audiologic manifestations[J].Otolaryngol Head Neck Surg,2011,145(2):295-302.

25 Jesus AA,Goldbach-Mansky R.IL-1 blockade in autoinflammatory syndromes[J].Annu Rev Med,2014,65(65):223-244.

26 Behringer J,Ryan M,Miller M,et al.Magnetic resonance imaging findings in a patient with cryopyrin-associated periodic syndrome:a rare hereditary multi-system inflammatory disorder[J].Neuroradiol J,2019,32(6):420-425.

27 Hirose K,Discolo CM,Keasler JR,et al.Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma[J].J Comp Neurol,2005,489(2):180-194.

28 Zhang W,Dai M,Fridberger A,et al.Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid-blood barrier[J].Proc Natl Acad Sci USA,2012,109(26):10388-10393.

29 Nakanishi H,Kawashima Y,Kurima K,et al.NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy[J].Proc Natl Acad Sci USA,2017,114(37):e7766-e7775.

30 Feldmann J,Prieur AM,Quartier P,et al.Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1,a gene highly expressed in polymorphonuclear cells and chondrocytes[J].Am J Hum Genet,2002,71(1):198-203.

31 Conforti-Andreoni C,Ricciardi-Castagnoli P,Mortellaro A.The inflammasomes in health and disease:from genetics to molecular mechanisms of autoinflammation and beyond[J].Cell Mol Immunol,2011,8(2):135-145.

32 Booshehri LM,Hoffman HM.CAPS and NLRP3[J].J Clin Immunol,2019,39(3):277-286.

33 Hoffman HM,Rosengren S,Boyle DL,et al.Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist[J].Lancet,2004,364(9447):1779-1785.

34 Kuemmerle-Deschner JB,Tyrrell PN,Koetter I,et al.Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome[J].Arthritis Rheum,2011,63(3):840-849.

35 Sibley CH,Plass N,Snow J,et al.Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra:a cohort study to determine three- and five-year outcomes[J].Arthritis Rheum,2012,64(7):2375-2386.

36 Marchica C,Zawawi F,Basodan D,et al.Resolution of unilateral sensorineural hearing loss in a pediatric patient with a severe phenotype of Muckle-Wells syndrome treated with Anakinra:a case report and review of the literature[J].J Otolaryngol Head Neck Surg,2018,47(1):9-9.

37 Iida Y,Wakiguchi H,Okazaki F,et al.Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene[J].Clin Rheumatol,2019,38(3):943-948.